TimesSquare Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

TimesSquare Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,237,365	Closed	-$27.8M	–	271
2016 Q4	$27.8M	Buy	2,237,365 +22,600	+1%	+$272K	0.19%	186
2016 Q3	$30.3M	Buy	+2,214,765	New	+$22.2M	0.2%	182
2013 Q3	–	Sell	-3,594,377	Closed	-$62.9M	–	259
2013 Q2	$62.9M	Buy	+3,594,377	New	+$63.7M	0.39%	94

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

TimesSquare Capital Management's ARIA Position: Q1 2017 in Review

TimesSquare Capital Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 2,237,365 shares — an estimated $27.8M sold.

TimesSquare Capital Management first reported a position in ARIA in Q2 2013 and held it in 3 quarters. The position peaked at $62.9M in Q2 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

TimesSquare Capital Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
TimesSquare Capital Management sold 2,237,365 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $27.8M.
TimesSquare Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
TimesSquare Capital Management's Ariad Pharmaceuticals Inc position peaked at $62.9M in Q2 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on TimesSquare Capital Management's 13F filing for Q1 2017, filed 12 May 2017.